InsidersTradesSigma
Follow the SyntheticMR AB (publ) share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, SyntheticMR AB (publ) has published 2 public disclosures. Market capitalisation: €51.8m. The latest transaction was reported on 17 February 2026 (Purchase). Among the most active insiders: Lena Åredal. The full history is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€141,472
2 ops.
Buy Volume
n/a
n/a
Sell Volume
37Σ signal
Fundamental score
Ranked 28,919 of 29,056 companies
5.2
score / 100
Value5
Quality5
FCF yld-26%
Earn yld-106%
EV/EBITDA·
ROE-35%
Gross mgn·
Net mgn-99%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 February 2026
Declarations2 total
329,113 shares@ €0.11410.053% mcap100.0% of flowAktieISIN SE0015987946FI:A003W052-1
1,000,000 shares@ €0.10390.15% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0027301995FI:A003V627-1
2 of 2 declarations
About SyntheticMR AB (publ)
SyntheticMR AB (publ) is a company focused on developing medical imaging software. It aims to enhance MRI techniques to optimize the diagnosis and treatment of diseases.